194. Lakartidningen. 2018 May 25;115. pii: E394.[Osteonecrosis of the jaws (ONJ) associated to antiresorptive treatment].[Article in Swedish]Larsson Wexell C(1), Kjellman A(2), Akre O(3).Author information: (1)Vastra Gotalandsregion - Avd. för käkkirurgi SÄS, Borås, Sweden - Avd. förkäkkirurgi Borås, Sweden.(2)Karolinska Universitetssjukhuset Urologiska kliniken - Stockholm, SwedenKarolinska Universitetssjukhuset Urologiska kliniken - Stockholm, Sweden.(3)Karolinska Universitetssjukhuset - Urologkliniken Stockholm, Sweden KarolinskaUniversitetssjukhuset - Urologkliniken Stockholm, Sweden.Osteonecrosis of the jaws (ONJ) has been associated to antiresorptive treatmentand is an increasing problem all over the world. ONJ is a severe adverse effectof antiresorptive treatment with bisphosphonate and denosumab used for treatment of osteoporosis, metastases from certain malignant conditions and as an adjuvant treatment in postmenopausal women with breast cancer, and of treatment withcertain chemotherapeutic drugs. In this paper the epidemiology, symptoms,diagnostic features, clinical findings, and treatment are reviewed. Guidelinesare presented for dental treatment, surgery and referral of patients onantiresorptive treatment.PMID: 29809272 